T1	Participants 88 145	treatment-experienced hepatitis C virus-infected patients
T3	Participants 701 816	pegylated IFN/RBV treatment-experienced Japanese patients with hepatitis C virus subtype 1b or genotype 2 infection
T2	Participants 818 889	Patients without cirrhosis (aged 18-75 years) with subtype 1b infection
T4	Participants 989 1023	patients with genotype 2 infection
T5	Participants 1264 1288	One hundred ten patients
T6	Participants 1815 1866	patients in whom prior pegylated IFN/RBV had failed
T7	Participants 1979 2047	Japanese patients with hepatitis C virus genotype 1b or 2a infection
